The immune system defends us against pathogens, yet sometimes it turns against our own tissues. Autoimmune diseases such as lupus, multiple sclerosis and rheumatoid arthritis arise when immune cells mistakenly attack the body, while allergies result from overreactions to harmless substances. Understanding these conditions requires decoding complex signalling networks of antibodies, cytokines and T‑cells. Artificial intelligence is emerging as a powerful tool to analyse immunological data and suggest new therapies.
Core statistical techniques drive these efforts. Classification models distinguish autoimmune flares from infection‑induced inflammation using blood markers; regression predicts symptom severity based on cytokine levels; clustering groups patients by immune profiles to identify disease subtypes. Systems biology models and graph neural networks map interactions between immune cells, genes and proteins. Predictive analytics forecasts disease progression and helps personalise treatment plans by identifying which biologic drugs may be most effective for an individual’s immune signature.
AI applications span diagnostics, monitoring and treatment. Machine learning algorithms analyse gene expression and epigenetic patterns to detect autoimmune diseases earlier. Deep learning models of T‑cell receptor repertoires reveal how the immune system recognises pathogens and self‑antigens. In allergy management, AI predicts pollen counts and personal exposure to recommend medication timing. Researchers use reinforcement learning to design vaccines and optimise immunotherapy regimens. Integrating single‑cell sequencing data and clinical outcomes helps identify biomarkers for responsiveness to emerging therapies.
However, modelling the immune system is challenging due to its complexity and variability across individuals. Autoimmune datasets are often small and imbalanced, making it difficult to train robust models. Data privacy is sensitive because immune profiles can reveal disease risks. Simplistic AI interpretations could mislead clinicians or patients if underlying biology is not understood. Collaborative research, diverse datasets and transparent algorithms are essential to translate computational insights into safe, equitable care. AI should guide, not dictate, clinical decisions, with immunologists and patients involved in designing and validating tools.
